[1] |
杨继建, 黄庆先, 陈丽. 胰岛细胞封装技术的研究进展[J]. 器官移植, 2021, 12(3): 336-343. DOI: 10.3969/j.issn.1674-7445.2021.03.013.YANG JJ, HUANG QX, CHEN L. Research progress on islet cell encapsulation technology[J]. Organ Transplant, 2021, 12(3): 336-343. DOI: 10.3969/j.issn.1674-7445.2021.03.013.
|
[2] |
韩毅, 董海青, 李胜, 等. 胰岛封装技术及其在胰岛移植中的应用[J]. 化学进展, 2018, 30(11): 1660-1668. DOI: 10.7536/PC180213.HAN Y, DONG HQ, LI S, et al. Pancreatic islet encapsulation technology and its application in islet transplantation[J]. Prog Chem, 2018, 30(11): 1660-1668. DOI: 10.7536/PC180213.
|
[3] |
SAMOJLIK MM, STABLER CL. Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in type 1 diabetes[J]. Acta Biomater, 2021, 133: 87-101. DOI: 10.1016/j.actbio.2021.05.039.
|
[4] |
KENDALL WF JR, OPARA EC. Polymeric materials for perm-selective coating of alginate microbeads[J]. Methods Mol Biol, 2017, 1479: 95-109. DOI: 10.1007/978-1-4939-6364-5_7.
|
[5] |
OPARA EC, MCQUILLING JP, FARNEY AC. Microencapsulation of pancreatic islets for use in a bioartificial pancreas[J]. Methods Mol Biol, 2013, 1001: 261-266. DOI: 10.1007/978-1-62703-363-3_21.
|
[6] |
CHEN T, YUAN J, DUNCANSON S, et al. Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression[J]. Am J Transplant, 2015, 15(3): 618-627. DOI: 10.1111/ajt.13049.
|
[7] |
SAFLEY SA, BARBER GF, HOLDCRAFT RW, et al. Multiple clinically relevant immunotherapies prolong the function of microencapsulated porcine islet xenografts in diabetic NOD mice without the use of anti-CD154 mAb[J]. Xenotransplantation, 2020, 27(4): e12577. DOI: 10.1111/xen.12577.
|
[8] |
HWANG PTJ, SHAH DK, GARCIA JA, et al. Encapsulation of human islets using a biomimetic self-assembled nanomatrix gel for protection against cellular inflammatory responses[J]. ACS Biomater Sci Eng, 2017, 3(9): 2110-2119. DOI: 10.1021/acsbiomaterials.7b00261.
|
[9] |
VERHEYEN CA, MORALES L, SUSSMAN J, et al. Characterization of polyethylene glycol-reinforced alginate microcapsules for mechanically stable cell immunoisolation[J]. Macromol Mater Eng, 2019, 304(4): 1800679. DOI: 10.1002/mame.201800679.
|
[10] |
TODA S, FATTAH A, ASAWA K, et al. Optimization of islet microencapsulation with thin polymer membranes for long-term stability[J]. Micromachines (Basel), 2019, 10(11): 755. DOI: 10.3390/mi10110755.
|
[11] |
MRIDHA AR, DARGAVILLE TR, DALTON PD, et al. Prevascularized retrievable hybrid implant to enhance function of subcutaneous encapsulated islets[J]. Tissue Eng Part A, 2020, DOI: 10.1089/ten.TEA.2020.0179 [Epub ahead of print].
|
[12] |
OPARA EC, KENDALL WF JR. Immunoisolation techniques for islet cell transplantation[J]. Expert Opin Biol Ther, 2002, 2(5): 503-511. DOI: 10.1517/14712598.2.5.503.
|
[13] |
OMAMI M, MCGARRIGLE JJ, REEDY M, et al. Islet microencapsulation: strategies and clinical status in diabetes[J]. Curr Diab Rep, 2017, 17(7): 47. DOI: 10.1007/s11892-017-0877-0.
|
[14] |
TAEMEH MA, SHIRAVANDI A, KORAYEM MA, et al. Fabrication challenges and trends in biomedical applications of alginate electrospun nanofibers[J]. Carbohydr Polym, 2020, 228: 115419. DOI: 10.1016/j.carbpol.2019.115419.
|
[15] |
DHARANI SR, SRINIVASAN R, SARATH R, et al. Recent progress on engineering microbial alginate lyases towards their versatile role in biotechnological applications[J]. Folia Microbiol (Praha), 2020, 65(6): 937-954. DOI: 10.1007/s12223-020-00802-8.
|
[16] |
CAMPANHA-RODRIGUES AL, GRAZIOLI G, OLIVEIRA TC, et al. Therapeutic potential of laminin-biodritin microcapsules for type 1 diabetes mellitus[J]. Cell Transplant, 2015, 24(2): 247-261. DOI: 10.3727/096368913X675160.
|
[17] |
HARRINGTON S, OTT L, KARANU F, et al. A versatile microencapsulation platform for hyaluronic acid and polyethylene glycol[J]. Tissue Eng Part A, 2021, 27(3/4): 153-164. DOI: 10.1089/ten.TEA.2019.0286.
|
[18] |
PARK HS, KIM JW, LEE SH, et al. Antifibrotic effect of rapamycin containing polyethylene glycol-coated alginate microcapsule in islet xenotransplantation[J]. J Tissue Eng Regen Med, 2017, 11(4): 1274-1284. DOI: 10.1002/term.2029.
|
[19] |
ALAGPULINSA DA, CAO JJL, DRISCOLL RK, et al. Alginate-microencapsulation of human stem cell-derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression[J]. Am J Transplant, 2019, 19(7): 1930-1940. DOI: 10.1111/ajt.15308.
|
[20] |
FARAH S, DOLOFF JC, MÜLLER P, et al. Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations[J]. Nat Mater, 2019, 18(8): 892-904. DOI: 10.1038/s41563-019-0377-5.
|
[21] |
AZADI SA, VASHEGHANI-FARAHANI E, HASHEMI-NAJAFBABADI S, et al. Co-encapsulation of pancreatic islets and pentoxifylline in alginate-based microcapsules with enhanced immunosuppressive effects[J]. Prog Biomater, 2016, 5: 101-109. DOI: 10.1007/s40204-016-0049-3.
|
[22] |
KIM MJ, PARK HS, KIM JW, et al. Suppression of fibrotic reactions of chitosan-alginate microcapsules containing porcine islets by dexamethasone surface coating[J]. Endocrinol Metab (Seoul), 2021, 36(1): 146-156. DOI: 10.3803/EnM.2021.879.
|
[23] |
MARFIL-GARZA BA, POLISHEVSKA K, PEPPER AR, et al. Current state and evidence of cellular encapsulation strategies in type 1 diabetes[J]. Compr Physiol, 2020, 10(3): 839-878. DOI: 10.1002/cphy.c190033.
|
[24] |
WU S, WANG L, FANG Y, et al. Advances in encapsulation and delivery strategies for islet transplantation[J]. Adv Healthc Mater, 2021, 10(20): e2100965. DOI: 10.1002/adhm.202100965.
|
[25] |
LIU Q, WANG X, CHIU A, et al. A zwitterionic polyurethane nanoporous device with low foreign-body response for islet encapsulation[J]. Adv Mater, 2021, 33(39): e2102852. DOI: 10.1002/adma.202102852.
|
[26] |
WEAVER JD, HEADEN DM, CORONEL MM, et al. Synthetic poly(ethylene glycol)-based microfluidic islet encapsulation reduces graft volume for delivery to highly vascularized and retrievable transplant site[J]. Am J Transplant, 2019, 19(5): 1315-1327. DOI: 10.1111/ajt.15168.
|
[27] |
DE KLERK E, HEBROK M. Stem cell-based clinical trials for diabetes mellitus[J]. Front Endocrinol (Lausanne), 2021, 12: 631463. DOI: 10.3389/fendo.2021.631463.
|
[28] |
SENIOR PA, PETTUS JH. Stem cell therapies for type 1 diabetes: current status and proposed road map to guide successful clinical trials[J]. Diabet Med, 2019, 36(3): 297-307. DOI: 10.1111/dme.13846.
|
[29] |
ZHU H, LI W, LIU Z, et al. Selection of implantation sites for transplantation of encapsulated pancreatic islets[J]. Tissue Eng Part B Rev, 2018, 24(3): 191-214. DOI: 10.1089/ten.TEB.2017.0311.
|
[30] |
DAMYAR K, FARAHMAND V, WHALEY D, et al. An overview of current advancements in pancreatic islet transplantation into the omentum[J]. Islets, 2021, 13(5/6): 115-120. DOI: 10.1080/19382014.2021.1954459.
|
[31] |
PAPAS KK, AVGOUSTINIATOS ES, SUSZYNSKI TM. Effect of oxygen supply on the size of implantable islet-containing encapsulation devices[J]. Panminerva Med, 2016, 58(1): 72-77.
|
[32] |
MCQUILLING JP, SITTADJODY S, PARETA R, et al. Retrieval of microencapsulated islet grafts for post-transplant evaluation[J]. Methods Mol Biol, 2017, 1479: 157-171. DOI: 10.1007/978-1-4939-6364-5_12.
|
[33] |
MCQUILLING JP, SITTADJODY S, PENDERGRAFT S, et al. Applications of particulate oxygen-generating substances (POGS) in the bioartificial pancreas[J]. Biomater Sci, 2017, 5(12): 2437-2447. DOI: 10.1039/c7bm00790f.
|
[34] |
SHARMA V, HUNCKLER M, RAMASUBRAMANIAN MK, et al. Microfluidic approach to cell microencapsulation[J]. Methods Mol Biol, 2017, 1479: 71-76. DOI: 10.1007/978-1-4939-6364-5_5.
|
[35] |
PATHAK S, PHAM TT, JEONG JH, et al. Immunoisolation of pancreatic islets via thin-layer surface modification[J]. J Control Release, 2019, 305: 176-193. DOI: 10.1016/j.jconrel.2019.04.034.
|
[36] |
CHEN Y, NGUYEN DT, KOKIL GR, et al. Microencapsulated islet-like microtissues with toroid geometry for enhanced cellular viability[J]. Acta Biomater, 2019, 97: 260-271. DOI: 10.1016/j.actbio.2019.08.018.
|
[37] |
CAÑIBANO-HERNÁNDEZ A, SAENZ DEL BURGO L, ESPONA-NOGUERA A, et al. Hyaluronic acid enhances cell survival of encapsulated insulin-producing cells in alginate-based microcapsules[J]. Int J Pharm, 2019, 557: 192-198. DOI: 10.1016/j.ijpharm.2018.12.062.
|
[38] |
WANG JK, CHEAM NMJ, IRVINE SA, et al. Interpenetrating network of alginate-human adipose extracellular matrix hydrogel for islet cells encapsulation[J]. Macromol Rapid Commun, 2020, 41(21): e2000275. DOI: 10.1002/marc.202000275.
|
[39] |
CAÑIBANO-HERNÁNDEZ A, SAENZ DEL BURGO L, ESPONA-NOGUERA A, et al. Hyaluronic acid promotes differentiation of mesenchymal stem cells from different sources toward pancreatic progenitors within three-dimensional alginate matrixes[J]. Mol Pharm, 2019, 16(2): 834-845. DOI: 10.1021/acs.molpharmaceut.8b01126.
|
[40] |
JARA C, OYARZUN-AMPUERO F, CARRIÓN F, et al. Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue[J]. Diabetol Metab Syndr, 2020, 12: 66. DOI: 10.1186/s13098-020-00573-9.
|
[41] |
MONTANUCCI P, PESCARA T, GRECO A, et al. Co-microencapsulation of human umbilical cord-derived mesenchymal stem and pancreatic islet-derived insulin producing cells in experimental type 1 diabetes[J]. Diabetes Metab Res Rev, 2021, 37(2): e3372. DOI: 10.1002/dmrr.3372.
|
[42] |
KOGAWA R, NAKAMURA K, MOCHIZUKI Y. A new islet transplantation method combining mesenchymal stem cells with recombinant peptide pieces, microencapsulated islets, and mesh bags[J]. Biomedicines, 2020, 8(9): 299. DOI: 10.3390/biomedicines8090299.
|
[43] |
MOCHIZUKI Y, KOGAWA R, TAKEGAMI R, et al. Co-microencapsulation of islets and MSC CellSaics, mosaic-like aggregates of MSCs and recombinant peptide pieces, and therapeutic effects of their subcutaneous transplantation on diabetes[J]. Biomedicines, 2020, 8(9): 318. DOI: 10.3390/biomedicines8090318.
|
[44] |
LAPORTE C, TUBBS E, PIERRON M, et al. Improved human islets' viability and functionality with mesenchymal stem cells and Arg-Gly-Asp tripeptides supplementation of alginate micro-encapsulated islets in vitro[J]. Biochem Biophys Res Commun, 2020, 528(4): 650-657. DOI: 10.1016/j.bbrc.2020.05.107.
|
[45] |
SONG N, SCHOLTEMEIJER M, SHAH K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential[J]. Trends Pharmacol Sci, 2020, 41(9): 653-664. DOI: 10.1016/j.tips.2020.06.009.
|
[46] |
SIM EZ, SHIRAKI N, KUME S. Recent progress in pancreatic islet cell therapy[J]. Inflamm Regen, 2021, 41(1): 1. DOI: 10.1186/s41232-020-00152-5.
|
[47] |
BOURGEOIS S, SAWATANI T, VAN MULDERS A, et al. Towards a functional cure for diabetes using stem cell-derived beta cells: are we there yet?[J]. Cells, 2021, 10(1): 191. DOI: 10.3390/cells10010191.
|
[48] |
SOLTANI A, KHAZAEI S, MIRTAGHI SM, et al. Generation of high yield insulin-producing cells (IPCs) from various sources of stem cells[J]. Vitam Horm, 2021, 116: 235-268. DOI: 10.1016/bs.vh.2021.02.006.
|
[49] |
KORYTNIKOV R, NOSTRO MC. Generation of polyhormonal and multipotent pancreatic progenitor lineages from human pluripotent stem cells[J]. Methods, 2016, 101: 56-64. DOI: 10.1016/j.ymeth.2015.10.017.
|
[50] |
王从义. 胰岛移植与糖尿病治疗[M]. 武汉: 华中科技大学出版社, 2019.
|
[51] |
HALLER C, PICCAND J, DE FRANCESCHI F, et al. Macroencapsulated human iPSC-derived pancreatic progenitors protect against STZ-induced hyperglycemia in mice[J]. Stem Cell Reports, 2019, 12(4): 787-800. DOI: 10.1016/j.stemcr.2019.02.002.
|
[52] |
NIHAD M, SHENOY PS, BOSE B. Cell therapy research for diabetes: pancreatic β cell differentiation from pluripotent stem cells[J]. Diabetes Res Clin Pract, 2021, 181: 109084. DOI: 10.1016/j.diabres.2021.109084.
|
[53] |
ViaCyte announces initiation of phase 2 study of encapsulated cell therapy for type 1 diabetes patients[EB/OL]. (2021-02-03). https://viacyte.com/press-releases/viacyte-announces-initiation-of-phase-2-study-of-encapsulated-cell-ther-apy-for-type-1-diabetes-patients/.
|
[54] |
CSOBONYEIOVA M, POLAK S, DANISOVIC L. Generation of pancreatic β-cells from iPSCs and their potential for type 1 diabetes mellitus replacement therapy and modelling[J]. Exp Clin Endocrinol Diabetes, 2020, 128(5): 339-346. DOI: 10.1055/a-0661-5873.
|